First human immunodeficiency virus type 1 sequences in the V3 region, nef and vpr genes from Papua New Guinea

被引:2
|
作者
Dwyer, DE
Ge, YC
Wang, B
Bolton, WV
McCormack, JG
Cunningham, AL
Saksena, NK
机构
[1] WESTMEAD HOSP,CIDM,WESTMEAD INST HLTH RES,CTR VIRUS RES,RETROVIRAL GENET LAB,WESTMEAD,NSW 2145,AUSTRALIA
[2] WESTMEAD HOSP,ICPMR,WESTMEAD,NSW 2145,AUSTRALIA
[3] NSW BLOOD BANK,DEPT VIROL & BIOCHEM,SYDNEY,NSW 2000,AUSTRALIA
[4] UNIV S BRISBANE,MATER HOSP,DEPT MED & INFECT DIS,BRISBANE 4101,AUSTRALIA
关键词
D O I
10.1089/aid.1997.13.625
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:625 / 627
页数:3
相关论文
共 50 条
  • [31] Characterization of HIV type 1 gp120 V3 region sequences from Ugandan infants
    Mellquist, JL
    Bowman, B
    Kasturi, L
    Guay, L
    Kataaha, P
    Mmiro, F
    Ndugwa, C
    Jackson, JB
    Eshleman, SH
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (15) : 1391 - 1395
  • [32] Genetic characterization of vif, vpr, and vpu sequences from long-term survivors of human immunodeficiency virus type 1 infection
    Zhang, LQ
    Huang, YX
    Yuan, HN
    Tuttleton, S
    Ho, DD
    VIROLOGY, 1997, 228 (02) : 340 - 349
  • [33] V3 LOOP OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENV PROTEIN - INTERPRETING SEQUENCE VARIABILITY
    MILICH, L
    MARGOLIN, B
    SWANSTROM, R
    JOURNAL OF VIROLOGY, 1993, 67 (09) : 5623 - 5634
  • [34] Immunogenicity comparison of a multi-antigenic peptide bearing V3 sequences of the human immunodeficiency virus type 1 with TAB9 protein in mice
    Cruz, LJ
    Quintana, D
    Iglesias, E
    Garcia, Y
    Huerta, V
    Garay, HE
    Duarte, C
    Reyes, O
    JOURNAL OF PEPTIDE SCIENCE, 2000, 6 (05) : 217 - 224
  • [35] EVOLUTION OF THE V3 ENVELOPE DOMAIN IN PROVIRAL SEQUENCES AND ISOLATES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DURING TRANSITION OF THE VIRAL BIOLOGICAL PHENOTYPE
    KUIKEN, CL
    DEJONG, JJ
    BAAN, E
    KEULEN, W
    TERSMETTE, M
    GOUDSMIT, J
    JOURNAL OF VIROLOGY, 1992, 66 (07) : 4622 - 4627
  • [36] Functional characterization of the V1V2 region of human immunodeficiency virus type 1
    Palmer, C
    Balfe, P
    Fox, D
    May, JC
    Frederiksson, R
    Fenyo, EM
    McKeating, JA
    VIROLOGY, 1996, 220 (02) : 436 - 449
  • [37] USE OF RANDOM SYSTEMATIC MUTAGENESIS TO GENERATE VIABLE HUMAN RHINOVIRUS 14 CHIMERAS DISPLAYING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 V3 LOOP SEQUENCES
    SMITH, AD
    RESNICK, DA
    ZHANG, AQ
    GEISLER, SC
    ARNOLD, E
    ARNOLD, GF
    JOURNAL OF VIROLOGY, 1994, 68 (01) : 575 - 579
  • [38] INTRAPATIENT VARIABILITY OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 ENVELOPE V3 LOOP
    SANKALE, JL
    DELATOUR, RS
    RENJIFO, B
    SIBY, T
    MBOUP, S
    MARLINK, RG
    ESSEX, ME
    KANKI, PJ
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (05) : 617 - 623
  • [39] OLIGOMERIZATION OF THE NEF PROTEIN FROM HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-1
    KIENZLE, N
    FREUND, J
    KALBITZER, HR
    MUELLERLANTZSCH, N
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 214 (02): : 451 - 457
  • [40] PRIMARY STRUCTURE OF THE V3 REGION OF GP120 FROM SEQUENTIAL HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES OBTAINED FROM PATIENTS FROM THE TIME OF SEROCONVERSION
    DISTLER, O
    MCQUEEN, PW
    TSANG, ML
    EVANS, LA
    HURREN, L
    BYRNE, C
    PENNY, R
    COOPER, DA
    DELANEY, SF
    JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (05): : 1384 - 1387